Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 57391 [2013-22613]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 181 / Wednesday, September 18, 2013 / Notices
By Order of the Federal Maritime
Commission.
Rachel E. Dickon,
Assistant Secretary.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[FR Doc. 2013–22716 Filed 9–17–13; 8:45 am]
Advisory Committee on Breast Cancer
in Young Women (ACBCYW)
BILLING CODE 6730–01–P
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Capacity Building Assistance
for High Impact HIV Prevention,
Funding Opportunity Announcement
(FOA) PS14–1403, Initial Review.
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned SEP:
emcdonald on DSK67QTVN1PROD with NOTICES
Times and Dates: 8:00 a.m.–8:00 p.m.,
November 12–15, 2013 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Capacity Building Assistance
for High Impact HIV Prevention’’, FOA
PS14–1403.
Contact Person for More Information:
Harriette A. Lynch, Public Health Analyst,
CDC, 1600 Clifton Road NE., Mailstop E07,
Atlanta, Georgia 30333, Telephone: (404)
718–8837.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–22613 Filed 9–17–13; 8:45 am]
BILLING CODE 4163–18–P
VerDate Mar<15>2010
16:45 Sep 17, 2013
Jkt 229001
Times and Dates:
8:00 a.m.–5:00 p.m. EST, October 31, 2013.
8:00 a.m.–1:00 p.m. EST, November 1, 2013.
Place: Centers for Disease Control and
Prevention, 4770 Buford Highway, Chamblee
Building 107, Rooms 1A and 1B, Atlanta,
Georgia 30341
Limited teleconference access is also
available. Login information is as follows:
For Public:
TOLL-FREE PHONE #: 888–989–8135
Participant passcode: BREASTCANCER
Net Conference URL: https://www.my
meetings.com/nc/join/
Conference number: PW7128790
Audience passcode: BREASTCANCER
or
Public can join the event directly: https://
www.mymeetings.com/nc/join.php?i=
PW7128790&p=BREASTCANCER&t=c
There is also a toll free number for anyone
outside of the USA: TOLL # 1–203–827–
7034
Participant passcode: BREASTCANCER
Status: Open to the public, limited only by
the space and phone lines available.
Purpose: The committee provides advice
and guidance to the Secretary, HHS; the
Assistant Secretary for Health; and the
Director, CDC, regarding the formative
research, development, implementation and
evaluation of evidence-based activities
designed to prevent breast cancer
(particularly among those at heightened risk)
and promote the early detection and support
of young women who develop the disease.
The advice provided by the Committee will
assist in ensuring scientific quality,
timeliness, utility, and dissemination of
credible appropriate messages and resource
materials.
Matters To Be Discussed: The agenda will
include discussions on the current and
emerging topics related to breast cancer in
young women. These may include risk
communication and health education, as well
as approaches to increase awareness of
clinicians/practitioners regarding topics such
as breast cancer risk, breast health,
symptoms, diagnosis, and treatment of breast
cancer in young women.
Agenda items are subject to change as
priorities dictate.
Online Registration Required: In order to
expedite the security clearance process
required for entry into a Federal building, all
ACBCYW attendees must register for the
meeting online at least 15 days in advance at
https://www.cdc.gov/cancer/breast/what_cdc_
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
57391
is_doing/meetings.htm. Please complete all
the required fields before submitting your
registration and submit no later than October
16, 2013. Each meeting day, attendees must
provide CDC staff and security with driver’s
license/state issued ID, or passport.
Contact Person for More Information:
Temeika L. Fairley, Ph.D., Designated Federal
Officer, National Center for Chronic Disease
Prevention and Health Promotion, CDC, 5770
Buford Hwy. NE., Mailstop K52, Atlanta,
Georgia 30341, Telephone (770) 488–4518,
Fax (770) 488–4760.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and Agency for Toxic Substances
and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2013–22612 Filed 9–17–13; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2013–N–1119]
Agency Information Collection
Activities; Proposed Collection;
Comment Request; Food Canning
Establishment Registration, Process
Filing, and Recordkeeping for Acidified
Foods and Thermally Processed LowAcid Foods in Hermetically Sealed
Containers
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or we) is
announcing an opportunity for public
comment on the proposed collection of
certain information by the Agency.
Under the Paperwork Reduction Act of
1995 (the PRA), Federal Agencies are
required to publish notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension of an
existing collection of information, and
to allow 60 days for public comment in
response to the notice. This notice
invites comments on the information
collection provisions of reporting and
recordkeeping requirements for firms
that process acidified foods and
thermally processed low-acid foods in
hermetically sealed containers, and
provides notice of and invites comments
on our proposed revisions to the
SUMMARY:
E:\FR\FM\18SEN1.SGM
18SEN1
]]>Agencies
[Federal Register Volume 78, Number 181 (Wednesday, September 18, 2013)]
[Notices]
[Page 57391]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-22613]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below concerns Capacity Building Assistance
for High Impact HIV Prevention, Funding Opportunity Announcement (FOA)
PS14-1403, Initial Review.
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the aforementioned SEP:
Times and Dates: 8:00 a.m.-8:00 p.m., November 12-15, 2013
(Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance
with provisions set forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director, Management Analysis
and Services Office, CDC, pursuant to Public Law 92-463.
Matters To Be Discussed: The meeting will include the initial
review, discussion, and evaluation of applications received in
response to ``Capacity Building Assistance for High Impact HIV
Prevention'', FOA PS14-1403.
Contact Person for More Information: Harriette A. Lynch, Public
Health Analyst, CDC, 1600 Clifton Road NE., Mailstop E07, Atlanta,
Georgia 30333, Telephone: (404) 718-8837.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2013-22613 Filed 9-17-13; 8:45 am]
BILLING CODE 4163-18-P
